Main Index --- Treatments Index --- Circulars Index
COMPASSION RESPONSE NETWORK CIRCULAR No 22
Pure Colloidal Silver + Oxyrich Project Results
By 22/September/2005, three advanced HIV/AIDS patients in Kinshasa, Democratic Republic of Congo, had commenced daily treatment, taking each day 5 mls of pure colloidal silver placed sub-lingually under the tongue, and held for a minute before swallowing. Soon after, each patient takes 2 mls of oxyrich in a drink of water. So to protect their identities, the patients are called patient A, patient B, and patient C.
Patient A
Of our three patients in Kinshasa, it was patient A who had been closest to death at the time of commencement of the pure colloidal silver + oxyrich treatment, and friends and family had been preparing for the time of funeral.
Six weeks after commencing treatment, patient A had a dispute with a local villager. This dispute was very fiery, and probably related to distribution of patient A’s material goods after his presumed imminent death. During the six weeks of treatment patient A had progressed so well that it had amazed so many in Kinshasa who knew and loved him, but the expectations of family and local village kin remained about the distribution of his possessions, and the minds of many of them were closed to the story of recovery of health of our three patients in Kinshasa receiving pure colloidal silver + oxyrich treatment. The incident with the local villager was exceedingly upsetting to patient A, who immediately went into a coma. His family or village kin took him to a hospital of their selection where he was denied the pure colloidal silver + oxyrich treatment and given other treatment. He was in coma for a few days, after which he awoke and asked to be put on again to his pure colloidal silver + oxyrich treatment. Apparently another dispute arose, and he died a few hours after. The dispute and going into coma and taking to another hospital all happened without our Kinshasa coworker Albert or his regular treating doctors being informed. Albert was advised only after patient A died.
In order to maintain three patients in our project, we invited a patient D to participate. Patient D had her pre-treatment blood tests on 22/November/05, and commenced treatment on 9/December/05, 2 ½ months after patients B and C commenced.
Blood Test Results
We have only pre-treatment blood test results for patient A, because he passed away before he was able to receive the 2-monthly blood tests.
Immunity System (CD4)
Patient A 8/6/05 (pre treatment), CD4 = 245
Patient B 8/6/05, (pre-treatment), CD4 = 150; 23/11/05 (2-monthly) CD4 = 769; 23/1/06 (4-monthly) CD4 = 852
Patient C 8/6/05, (pre-treatment), CD4 = 860; 23/11/05 (2-monthly) CD4 = 752; 23/1/06 (4-monthly) CD4 = 974
Patient D CD4: 22/11/05 pre-treatment 937 ; 9/2/06 2-months 1,285 ; 4-monthly due April/06
CD4 is immunity cell count. Any count above 600 is healthy and normal. Around 200 reflects severe depletion of immunity cells (lymphocytes) and the patient is thus severely at risk from secondary infections.
Though patients C and D retained a healthy immunity system, even before our treatment, patient B’s pre-treatment readings were dangerously low. These have now recovered again to healthy levels, indicating restoration and healing of her immunity system.
Viral Load Count (bDNA)
Patient A pre-treatment 956,348: died before able to take 2-monthly
Patient B pre-treatment 184,701: 2-monthly 85,425: 4-monthly 657,729
Patient C pre-treatment 667,548: 2-monthly 244,295: 4-monthly 495,230
Patient D pre-treatment 385,662: 2-monthly 274,552: 4-monthly due April/06
These viral load count figures are most disappointing. At the 4-monthly blood tests, the viral load count for patients B and C has again blown out to dangerously high proportions. This suggests there may be a source of hibernating HIV infection that is not being affected by our treatment.
Health Progress for patients B, C and D
In general, Albert notes, “in the beginning of the treatment all the symptoms disappear: diarrhea, scabies and other effects disappear, the appetite comes back ...then after some weeks and months the symptoms reappear. It seems to be verified for nearly all our patients.”
Patient B
Patient B is a 57 year old woman, whose illness began in 2002. Her treating doctor had hidden the diagnosis of AIDS from her, suggesting she had malaria or typhoid. Recent blood tests have confirmed her HIV infection. She was living by the coast and had recently moved to Kinshasa for treatment and care with family. Her symptoms are generally similar to those of patient A, but are not so extreme, although in the few days before receiving the pure colloidal silver treatment, she had a fever and a serious crisis.
Fevers, candidose and diarrhea, all problems before the pure colloidal silver treatment, have now all stopped. Her sleep is again normal.
She continued for a while to have pains in legs, but these pains have now disappeared. She is unable to lift heavy things and continues to express tiredness for which she needs much rest. She continues to have periods of dizziness.
Before colloidal silver treatment, she had lost her appetite and had much difficulty in feeding herself. She was aware of the approach of death. Since treatment began, she commenced properly feeding herself with fruits and soups. Now her appetite has fully returned, and she eagerly eats solid foods. This transformation in her appetite and feeding has given joy to her family.
Recently, Albert reports on patient B, “She complains about tiredness and the continuous thinning, but in general she is in good health. She also complains about hunger, lack of means to feed herself.”
Patient C
Patient C is a 43 year old woman, who first became ill in 2001. Though she has tested as infected with HIV, she had been the least affected of the three patients. Her main symptoms related to rashes and itches, for which she had taken antibiotics (now she has stopped taking these)
She also had fevers, diarrhea, and headaches, but since commencing the taking of pure colloidal silver, her general health has improved.
She went into a deep-sleep at the commencement of the pure colloidal silver treatment, but she has now adjusted and again sleeps well.
Albert’s recent report on patient C states, “She lately had a crisis, she has got thinner recently, again she has lost her appetite. Diarrheas have appeared again, pains, itches, wounds to the vagina... .Seemingly there is not enough hope for her.”
Patient D
Concerning patient D, Albert reports, “There are good results for her: stop of diarrheas, the appetite came back, the patient is again active. She goes well, there are not any more scabies. Fevers and headaches have reduced. She doesn't know any more pains as before, no itches but the thinning doesn't improve.”
Glyconutritionals Project
In Dar-es-Salaam, Tanzania, an advanced HIV/AIDS patient named Bennett commenced on 16/October/2005 a treatment involving glyconutritionals.
The treatment is by way of three types of tablets, Ambrotose AO, Plus and Catalyst, taken each day. The treatment is essentially a nutritional supplement. It has good reports of positive results with HIV/AIDS patients. Our intention was to do a complete 6-months testing trial with Bennett to provide a one-person trial to commence our own assessment of its value.
Early reports during the first week were very positive. Bennett reported that his body pains had disappeared. Part of his left foot that had been swollen, was back to normal. His movements had stabilised. The itchiness in various parts of the body that he had been experiencing were gone. His diarrhea was clearing. He was confident and joyful in his dramatic improvement in general health.
Then most unexpectedly on 25/October, following a normal night’s sleep, Bennett went into a coma, and was taken to hospital. A few days later, Bennett recovered from coma and was talking well with relatives and friends and we had hopes of getting him back home. For unknown reason the doctor set up an infusion of quinine assuming Bennett had malaria attack. No blood slide examination was made to confirm the presence of malaria parasites. The infusion threw Bennett back into coma.
By 1/November/05, Bennett had recovered his consciousness, commenced talking and eating with a soft diet, and began slowly to regain his health. Then suddenly on the morning of 3/November/2005, after taking his breakfast, Bennett fell into unconsciousness, and by 9am he was certified dead. The doctors have determined that Bennett died from a meningitis infection.
Shadrack, our coworker in Dar-es-Salaam, is in process of seeking another HIV/AIDS patient to resume taking of the glyconutritionals treatment left remaining after the death of Bennett.
Kinshasa Compassion Response Centre
The Kinshasa Compassion Response Centre has been meeting monthly now on the 12th day of every month, for over a year now, ever since the Imusil project began.
You will recall that in November 2004, a gift of US$845 from a CRN coworker was given to the Kinshasa centre, to fund a shop project. Héritier, the orphan son of deceased HIV/AIDS patient Mathieu, would run the shop and earn for himself US$100 a month, barely sufficient to support himself and his six orphan sisters, who otherwise would have been forced out onto the streets. This experiment has prospered. Each month, from the monthly earnings from the shop, payment is made for a meal for all patients attending the monthly meeting, as well as transport costs. Héritier withdraws his monthly wage, and the remainder goes to increase the shop stock and therefore the business in the shop steadily grows. Last month’s report indicated that the shop stock has increased to over US$2,000, and Héritier’s wage has been increased to US$200 a month.
Despite the recent poor blood test results, the pure colloidal silver + oxyrich project has been successful in that all three patients presently receiving treatment are continuing to report fair health (apart from patient C who has had a recent relapse in health). It has for a long time been CRN policy, that as soon as a patient’s group is strong and healthy enough, we will offer them guidance in how to kick-start a movement to provide, with CRN support, a comprehensive compassion response to the HIV/AIDS pandemic. A vital element of such a movement is that its founders come from those Africans who know directly from first hand experience what it is like to suffer the tragedies associated with HIV/AIDS. Thus, as soon as an African service group becomes sufficiently self-reliant and healthy, we will transfer decision making and organisational responsibilities for future CRN projects over to the local African group.
For over a year now, I have been sending an inspirational message to the members of the Kinshasa Compassion Response Centre to be read at their monthly meeting. They then provide a report which Albert sends me each month.
From the February 2006 meeting, Albert reports,
“We agree that goodwill energy is meaningful, we are inclined to learn some further, to experiment with it, to make it advance, and from it, to build the People's Movement. You can count on us for this enterprise, there is not any doubt. It is something of marvelous that it was given to us to attend the blossoming of such an experience. It is obvious that it is an honor for us to establish the bases of such an experience. Why would not we do it? Let's go there step-by-step!
“Yes, we are ready to serve the humanity and to use the energy of goodwill to help us accomplish our objectives.
“As a group we want to come out of our AIDS patients misery, to organize a solidarity with the other AIDS African patients, and to make emerge a People's Movement of Africa.
“Yes, we affirm with you that "There exists a simple, cheap and effective treatment and cure for HIV/AIDS. Let that treatment and cure be discovered, demonstrated to and shared with all throughout humanity who suffer from this disease.”
From the March 2006 meeting, Albert reports,
“We get ready to progressively work in the sense of the group work evolution, work that can be useful to Africa and especially concerning the African AIDS patients, and the fight to defend later before Africa and before the World an efficient alternative treatment for HIV/AIDS.”
“The Response Centre has been contacted by an increasing number of AIDS patients. Our capacity to answer to their needs is nearly hopeless, apart from our advice and our promises. As our patients inform friends about our work and about the CRN service, then many come to look for help, to find possibly a new and efficient treatment for AIDS, to also find material help in nature, food, dresses, money... They come, contacted either by the group of our patients, by their testimonies, or by other people who report about us. We have already recorded the request of about thirty patients who call for our help. Among them there are two AIDS patients who come frequently.”
Funding Situation
Budget estimates for the pure colloidal silver + oxyrich project for three HIV/AIDS patients in Kinshasa, came to A$7,447 = US$5,585. Budget estimates for the glyconutritionals project for one HIV/AIDS patient came to A$2,580 = US$1,935. The budget for these two projects together comes to A$10,027 = US$7,520.
Full funding for these projects has now been made in full, and Compassion Response Network wishes to thank from our heart the generosity of those donors who have contributed the necessary funds. These funds received have ensured full payment of the next glyconutritionals patient in Dar-es-Salaam, though no funds are at this time available for conducting another trial in Kinshasa or elsewhere. The bank account for CRN is only at A$170.
The situation for the three HIV/AIDS patients in Kinshasa presently causes much concern for us. They have clearly benefited from the treatment, but not enough to ensure long term health. What will happen with them, when the 6 months of pure colloidal silver + oxyrich treatment ends? Patients B and D remain in fair health, but patient C has recently had serious crises, and there are serious concerns for her life.
The treatment of pure colloidal silver + oxyrich has clearly proven to be inadequate to ensure their long term health. CRN has therefore purchased a new treatment of Sutherlandia herbal tablets, sufficient to supply three patients each for six months. This is a herbal treatment coming from southern Africa that is reputedly wonderful in treatment of HIV/AIDS. This Sutherlandia treatment is being delivered to our Perth office, and funds have been made available for its courier delivery to Kinshasa.
It is vital that this Sutherlandia product be further sponsored to allow a comprehensive trial involving three advanced HIV/AIDS patients each receiving treatment over 6 months, and having proper blood tests and medical supervision. The cost for such a treatment for pure colloidal silver + oxyrich came to A$7,500 = US$5,600. A similar amount must now be raised to fund the Sutherlandia trials, and until such an amount is received or has been committed, it is pointless transferring the Sutherlandia tablets to Kinshasa. Once this product is in Kinshasa, and the trial has been fully funded, then we shall leave it to the local Kinshasa group to decide who shall receive this new treatment. Whether it is received by the three present pure colloidal silver patients, or by three new HIV/AIDS patients the Kinshasa group shall decide when the funds are available. In the meantime we must pray that some out there will open their hearts to provide the funds that will facilitate a further project in Africa and renewed hope for the three patients who are to receive the treatment.
Compassion Response Network is a charitable organisation, running upon the generosity of donations from the general public. Without your continued help and financial assistance, our work in Africa will come to nothing.
Yours with love and light,
David Keane,
Secretary, Compassion Response Network.